contract manufacturing

According to MarketsandMarkets, the global pharmaceutical contract development and manufacturing market is projected to reach USD 126.63 billion by 2024 from USD 90 billion in 2019, at a CAGR of 7.1% during the forecast period. Growth in this market is driven by the rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. Also, the increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements…

Keep Reading